A subscription to JoVE is required to view this content. Sign in or start your free trial.
In this study, a rat model of induction of periodontitis is presented via a combination of retentive ligature and repetitive injections of lipopolysaccharide derived from Porphyromonas gingivalis, over 14 days around the first maxillary molars. The ligation and LPS injection techniques were effective in inducing peridontitis, resulting in alveolar bone loss and inflammation.
Periodontitis (PD) is a highly prevalent, chronic immune-inflammatory disease of the periodontium, that results in a loss of gingival soft tissue, periodontal ligament, cementum, and alveolar bone. In this study, a simple method of PD induction in rats is described. We provide detailed instructions for placement of the ligature model around the first maxillary molars (M1) and a combination of injections of lipopolysaccharide (LPS), derived from Porphyromonas gingivalis at the mesio-palatal side of the M1. The induction of periodontitis was maintained for 14 days, promoting the accumulation of bacteria biofilm and inflammation. To validate the animal model, IL-1β, a key inflammatory mediator, was determined by an immunoassay in the gingival crevicular fluid (GCF), and alveolar bone loss was calculated using cone beam computed tomography (CBCT). This technique was effective in promoting gingiva recession, alveolar bone loss, and an increase in IL-1β levels in the GCF at the end of the experimental procedure after 14 days. This method was effective in inducing PD, thus being able to be used in studies on disease progression mechanisms and future possible treatments.
Periodontitis (PD) is the sixth most prevalent public health condition worldwide, affecting approximately 11% of the total population, being an advanced, irreversible, and destructive form of periodontal disease1,2. PD is an inflammatory process that affects the gingival and periodontal tissues, which results in gingiva recession, apical migration of the junctional epithelium with pocket development, and the loss of alveolar bone3. Furthermore, PD is associated with several systemic diseases, including cardiovascular disease, obesity, diabetes, and rheumatoid arthritis, for which enviro....
NOTE: The experimental protocol of the study was approved by the Ethical Committee of Animal Experimentation of the Balearic Islands Health Research Institute (CEEA-UIB; reference number 163/03/21).
1. Animal anesthesia and procedure preparation
A timeline of the experimental steps is presented in Figure 1. Figure 2A shows an image of the mandibula after surgical intervention, with ligature placement around the sulcus of the M1 at time 0 of the experiment. Figure 2B shows how, after 14 days of the procedure, the ligature around the M1 enters the gingival sulcus, causing inflammation of the gingiva and infiltrating accumulation.
This method describes the induction of PD in rats following a combined technique of Pg-LPS injections and ligature placement around the M1, revealing that significant changes in the periodontal tissues and alveolar bone could be induced in 14 days following this method.
During this procedure, attention to different critical steps must be provided. During animal anesthesia and procedure preparation, assessing the proper anesthesia during the surgical process is critical for its success.......
This work was supported by Fundació Universitat-Empresa de les Illes Balears (Proof of concept call 2020), by the Instituto de Salud Carlos III, Ministerio de Economía y Competividad, co-funded by the ESF European Social Fund and the ERDF European Regional Development Fund (contract to M.M.B; FI18/00104) and by the Direcció General d'Investigació, Conselleria d'Investigació, Govern Balear (contract to M.M.F.C; FPI/040/2020). The authors thank Dr. Anna Tomás and Maria Tortosa for their help at the experimental surgery and platform of IdISBa. Finally, thanks to ADEMA School of Dentistry for the access to the CBCT scanner.
....Name | Company | Catalog Number | Comments |
Adsorbent paper point nº30 | Proclinc | 8187 | |
Aprotinin | Sigma-Aldrich | A1153 | |
Atipamezole | Dechra | 573751.5 | Revanzol 5 mg/mL |
Braided silk ligature (5/0) | Laboratorio Arago Sl | 613112 | |
Buprenorphine | Richter pharma | 578816.6 | Bupaq 0.3 mg/mL |
Cone-beam computed tomography (CBCT) Scanner | MyRay | hyperion X9 | Model Hyperion X9 |
CTAn software | SkyScan | Version 1.13.4.0 | |
Dental explorer | Proclinc | 99743 | |
Diamond lance-shaped bur | Dentaltix | IT21517 | |
Food maintenance diet | Sodispain research | ROD14 | |
Heated surgical platform | PetSavers | ||
Hollenback carver | Hu-FRIEDY | HF45234 | |
Hypodermic needle | BD | 300600 | 25G X 5/8” - 0,5 X 16 MM |
Isoflurane | Karizoo | Isoflutek 1000mg/g | |
Ketamine | Dechra | 581140.6 | Anesketin 100 mg/mL |
Lipopolysaccharide derived from P.Gingivalis | InvivoGen | TLRL-PGLPS | |
Methanol | Fisher Scientific | M/4000/PB08 | |
Micro needle holter | Fehling Surgical Instruments | KOT-6 | |
Microsurgical pliers | KLS Martin | 12-384-06-07 | |
microsurgical scissors | S&T microsurgical instruments | SDC-15 RV | |
Monitor iMEC 8 Vet | Mindray | ||
Multiplex bead immunoassay | Procartaplex, Thermo fisher Scientific | PPX-05 | |
Paraformaldehyde (PFA) | Sigma-Aldrich | 8187151000 | |
Periosteal microsurgical elevator | Dentaltix | CU19112468 | |
Phenylmethylsulfonylfluoride (PMSF) | Roche | 10837091001 | |
Phosphate Buffer Solution (PBS) | Capricorn Scientific | PBS-1A | |
PhosSTOP | Roche | 4906845001 | Commercial phosphatase inhibitor tablet |
Plastic vial | SPL Lifesciencies | 60015 | 1.5mL |
Saline | Cinfa | 204024.3 | |
Stereo Microscope | Zeiss | Model SteREO Discovery.V12 | |
Surgical loupes led light | Zeiss | ||
Surgical scissors | Zepf Surgical | 08-1701-17 | |
Syringe | BD plastipak | 303172 | 1mL |
Veterinary dental micromotor | Eickemeyer | 174028 | |
Xylazine | Calier | 20102-003 | Xilagesic 20 mg/mL |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved